Table 1.
Patient group demographics
| LigaSure™ | Non-LigaSure™ | P-value | |
|---|---|---|---|
| Number of patients | 114 | 34 | |
| Mean age (range) | 64.4 (38–88) | 61 (13–83) | 0.287 |
| Number of females (%) | 62 (54.4) | 15 (44.1) | 0.293 |
| Past medical history, n (%) | |||
| Coronary artery disease | 14 (12.3) | 6 (17.6) | 0.422 |
| Chronic obstructive pulmonary disease, asthma, and/or obstructive sleep apnoea | 18 (15.8) | 6 (17.6) | 0.797 |
| Diabetes mellitus | 39 (34.2) | 11 (32.4) | 0.841 |
| Smoking | 31 (27.2) | 5 (14.7) | 0.136 |
| Mean pre-operative serum albumin level, g/dl (range) | 3.5 (1.8–4.5) | 3.4 (0.6–4.5) | 0.328 |
| Neoadjuvant therapy (pancreatic adenocarcinoma), n (%) | 7 (6.1) | 2 (5.9) | 0.945 |
| Diagnosis, n (%) | |||
| Adenocarcinoma | 73 (64.0) | 21 (61.8) | |
| Pancreatic | 59 (51.8) | 16 (47.1) | 0.631 |
| Duodenal | 12 (10.5) | 4 (11.8) | |
| Common bile duct | 2 (1.8) | 1 (2.9) | |
| Intraductal papillary mucinous neoplasm | 12 (10.5) | 4 (11.8) | |
| Endocrine neoplasm | 8 (7.0) | 2 (5.9) | |
| Other tumours | 8 (7.0) | 6 (17.6) | |